Digg icon reddit icon Stumbleupon icon
Print Email     Print Edition Stories

Thursday, February 11, 2010

Wadsworth Medical Tech brings manufacturing to Mass.

By Brendan Lynch

Westborough-based Wadsworth Medical Technologies Inc. reports its DermaLOC wound closure system and its components will be manufactured by Haverhill-based Baril Corp. and Sturbridge-based G&F Industries Inc. in what the company said is an effort to create jobs in Massachusetts and increase the state’s tax base.

Financial terms of the deal were not disclosed. Baril and G&F replace two out-of-state manfacturers for DermaLOC, which applies tension to skin wounds to close them without anesthesia or sutures.

Last April, Wadsworth was one of seven companies receiving a loan from the Massachusetts Life Sciences Center. The companies getting loans were eligible for as much a $500,000, which was intended to support R&D, manufacturing and sales.

Wadsworth won FDA approval for DermaLOC in September.

Baril specializes in die cutting, laser cutting, multi-layer laminating and tool making for the medical device, clean technology and defense markets. G&F specialized in custom injection molding for medical and technical devices.
 

Comments

If you are commenting using a Facebook account, your profile information may be displayed with your comment depending on your privacy settings. By leaving the 'Post to Facebook' box selected, your comment will be published to your Facebook profile in addition to the space below.

Digg icon reddit icon Stumbleupon icon
Contact Editor Latest News

Tech Pulse Poll

What's your level of interest in Pinterest?



View Results

Stay Informed
Check which newsletter you'd like to receive.
TechFlash (Daily)
BioFlash (Daily)
GreenFlash (Weekly)
Startup Report (Weekly)
Breaking news, MHT events, local announcements
RSS feeds
Your email:

Affiliate publications: ACBJ.com, Boston Business Journal, Bizjournals.com, Portfolio.com, Wired.com

Web Site Developed by Neptune Web, Inc.

Use of and/or registration on any portion of this site constitutes acceptance of our User Agreement and Privacy Policy. About our ads.